Live feed08:00:42·345dSECFilingvia QuantisnowAytu BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.AYTU· Aytu BioPharma Inc.Health CareOriginal source
